IMPACT OF TAPERING OF IMMUNOSUPPRESSIVE THERAPY OR GLUCOCORTICOIDS ON DAMAGE ACCRUAL AFTER ACHIEVING LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LARGE MULTINATIONAL COHORT